Novavax
Novavax announces vaccine’s high efficacy against original and variant COVID-19 strains
March 12, 2021Medical Communications COVID-19, Novavax, vaccines
Novavax has announced final efficacy of 96.4% against mild, moderate, and severe disease caused by the original COVID-19 strain in …
South Korea orders 46 million more Novavax and Pfizer COVID-19 vaccines
February 16, 2021Manufacturing and Production COVID, COVID-19, Novavax, Pfizer, Vaccine, south korea
South Korea has arranged deals with Novavax and Pfizer-BioNTech to buy enough COVID-19 vaccines for 23 million more people.
Novavax COVID-19 vaccine shows almost 90% efficacy in Phase III trial
January 29, 2021Medical Communications COVID-19, Novavax
Novavax has announced that its COVID-19 vaccine candidate, NVX-CoV2373, demonstrated an efficacy of 89.3% in its UK Phase III trial. …
Novavax secures deal with New Zealand for 10.7m doses of COVID-19 vaccine
December 17, 2020Sales and Marketing COVID-19, Novavax, Vaccine
Novavax has announced an Advance Purchase Agreement with New Zealand for the purchase of 10.7 million doses of NVX-CoV2373, the …
Novavax and Janssen commit 90 million COVID-19 vaccine doses to UK Government with two new deals
August 14, 2020Manufacturing and Production, Medical Communications, Sales and Marketing COVID-19, J&J, JJ, Novavax, UK, pharma
The UK Government has signed a new deal with Johnson & Johnson and Novavax to secure 90 million orders of …
Novavax inks deal to deliver one billion COVID-19 vaccine doses in India and other regions
August 10, 2020Manufacturing and Production, Research and Development, Sales and Marketing COVID-19, India, Novavax, Serum Institute of India Private Limited, Vaccine
Novavax is partnering up with the Serum Institute of India Private Limited (SIIPL) in a licensing deal to development and …
Early promise from Novavax’s vaccine candidate for COVID-19
August 7, 2020Medical Communications, Research and Development COVID-19, Novavax, Vaccine
New Phase 1/2 on Novavax’s COVID-19 vaccine candidate NVX‑CoV2373 has shown that the therapy generated “robust antibody responses” when used …
Novavax cuts works force by a third in struggle to restructure
November 10, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cost cutting, Jobs, Novavax, losses
Novavax released the news that it would cut away 30% of its workforce alongside third quarter results that revenues were …
Novavax rides high on crest of RSV vaccine wave
August 12, 2015Research and Development AbbVie, MedImmune, Novavax, RSV, vaccines
The vaccine development company Novavax has announced positive top-line data from a mid-stage clinical trial of its candidate vaccine against …
Novavax makes manufacturing promotions
June 16, 2010Manufacturing and Production, Research and Development Novavax, appointment, manufacturing and production, research and development
US biotech company Novavax has made a brace of manufacturing management promotions. It has appointed John Madsen as head of …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
